Structurally, cost reduction drives, expanding of complex procedures and profitability of new hospitals and AHL remain key management focus areas, analysts said.
The government should move quickly to ramp up the availability of the COVID-19 vaccine in the country by enhancing domestic production as well as increasing procurement from abroad, Apollo Hospitals Joint MD Sangita Reddy said on Monday. Reddy also urged the government to utilise all public and private hospitals at the district level for vaccination purposes. "The challenge of India#vaccinationstrategy is not admin as much as supply. I urge R #govt to move quickly on ramping up domestic prod, enhance intl procure, seek Intl aid in the form of vaccine & establish a dist network of all Pub & Pvt hospitals 2 accelerate the pace of inoculation," Reddy said in a post on micro-blogging site Twitter. Last week, Reddy had suggested the government to take decisive actions to ramp up the production of COVID vaccines and streamline the inoculation processes to include citizens who do not have access to the internet. "I urge @PMOIndia 2 take Bold & decisive actions to ramp up #COVID .
The final issue price, including any discount to the floor price, will be determined in the fund-raising committee meeting on January 22, 2021
The pharmacy business is one the main segments that helped Apollo cushion from any big shocks due to the pandemic
Almost 615 companies, including BPCL, Page Industries, Nestle India, and Apollo Hospitals Enterprise, are scheduled to announce their December quarter results today
The promoter group shareholding in AHEL was around 30.80 per cent at the end of September, 2019, of which around 66.19 per cent is pledged, according to regulatory filing
Promoters say the plan to reduce pledged shares in the firm to 50% in a few months is on track
The company's consolidated net profit more than doubled at Rs 49 crore in Q1FY20 as against a PAT of Rs 23 crore in the year ago quarter.
The stock hits 52-week high of Rs 1,324, up 5%, rallied 43%, as compared to 3% rise in the S&P BSE Sensex during past six months.
Targets Rs 100 billion revenue in the next five years
IHH Healthcare has sold its entire stake in AHEL last year
Apollo Hospitals Enterprise Ltd (AHEL) is looking at increasing contribution of private labels in its pharmacy business. Private label accounts to around 6.5 per cent of the pharmacy business at present and the company is envisaging to take this up to 20 per cent of the business in five years, said a senior mangement official. Adding new products to the private label portfolio, with focus on health and wellness products, and tie up with international brands are some of the strategies to achieve the aim. It already has tied up with UK-based health and wellness stores major Holland & Barret International and would look at similar tie ups in future."The private label business is currently 6.5 per cent, but our aim is to take it to over 20 per cent in next few years," said Akhileswaran Krishnan, chief financial officer of AHEL.The road map is to add more products and the company has specific product lines which it can expand over a period of time. Another focus would be on more tie ...
The stock slipped 7% to Rs 1,069, its lowest level since October 23, 2014 on BSE in intra-day trade.